External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase
Prostate Cancer UK, UK Medical Research Council, Cancer Research UK, John Black Charitable Foundation, Prostate Cancer Foundation, Sanofi Aventis, Janssen, Astellas, Novartis, Artera.
Authors
- Gerhardt Attard (ORCID: https://orcid.org/0000-0002-4811-7983)
- Jacqueline Griffin (ORCID: https://orcid.org/0000-0002-3928-3891)
- Ashwin Sachdeva (ORCID: https://orcid.org/0000-0002-7359-7114)
- Silke Gillessen (ORCID: https://orcid.org/0000-0001-5746-6555)
- Larissa Mendes
- Douwe van der Wal (ORCID: https://orcid.org/0000-0003-2323-1357)
- Mahesh Parmar (ORCID: https://orcid.org/0000-0003-0166-1700)
- Anna Wingate (ORCID: https://orcid.org/0009-0008-4965-7093)
- Tamara R. Todorović (ORCID: https://orcid.org/0000-0002-7740-3639)
- Sara Santos Vidal
- Nicholas David James (ORCID: https://orcid.org/0000-0002-7314-8204)
- Charles Parker (ORCID: https://orcid.org/0000-0001-6488-7315)
- Marina Parry (ORCID: https://orcid.org/0000-0003-3278-9491)
- Emily Grist
- William Cross (ORCID: https://orcid.org/0000-0001-9276-3053)
- Claire Amos
- Leila Zakka
- Emmalyn Chen (ORCID: https://orcid.org/0000-0002-4179-5773)
- Rikiya Yamashita (ORCID: https://orcid.org/0000-0002-2686-2333)
- Matthew R. Sydes (ORCID: https://orcid.org/0000-0002-9323-1371)
- Noel W. Clarke (ORCID: https://orcid.org/0000-0001-7776-8059)
- Andre Esteva (ORCID: https://orcid.org/0000-0003-1937-9682)
- Phuoc T. Tran (ORCID: https://orcid.org/0000-0002-0147-0376)
- Sharanpreet Lall
- Daniel M. Berney (ORCID: https://orcid.org/0000-0001-5474-8696)
- Daniel Eidelberg Spratt (ORCID: https://orcid.org/0000-0002-5973-4741)
- Vinnie Y.T. Liu (ORCID: https://orcid.org/0000-0002-7152-6830)
- Louise Brown (ORCID: https://orcid.org/0000-0003-2827-6634)
- Akinori Mitani (ORCID: https://orcid.org/0000-0001-8088-6021)
- Nafisah B Atako
- Daniel Wetterskog (ORCID: https://orcid.org/0000-0003-4163-6438)
- M.D. Brown (ORCID: https://orcid.org/0000-0003-1322-4671)
- Chris Parker (ORCID: https://orcid.org/0000-0001-6512-124X)
- Felix Y. Feng (ORCID: https://orcid.org/0000-0001-9756-4037)
- Huei–Chung Huang
- Robert J. Jones (ORCID: https://orcid.org/0000-0003-0759-8968)
- Suparna Thakali
- Miriam Goncalves
- L.R. Murphy
- Songwan Joun
Institutions
- University of Maryland, Baltimore (US)
- Royal Marsden NHS Foundation Trust (GB)
- Institute of Cancer Research (GB)
- Queen Mary University of London (GB)
- University of California, San Francisco (US)
- Beatson West of Scotland Cancer Centre (GB)
- Cancer Research UK (GB)
- St James's University Hospital (GB)
- MRC Clinical Trials Unit at UCL (GB)
- University Hospitals Seidman Cancer Center (US)
- Cancer Research UK Manchester Institute (GB)
- CRUK Lung Cancer Centre of Excellence (GB)
- Artistic Realization Technologies (US)
- University College London (GB)
- Università della Svizzera italiana (CH)
- Case Western Reserve University (US)
- University of Glasgow (GB)
Publication Details
- Journal
- The Lancet Digital Health
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1016/j.landig.2025.100885
- Citations
- 10
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 15.18
Funders
- U.S. Department of Defense
- American Association for Cancer Research
- Prostate Cancer Foundation
- American Society for Radiation Oncology
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- RefleXion Medical
- Varian Medical Systems
- CSL Behring
- Boston Scientific Corporation
- Regeneron Pharmaceuticals
- Exelixis
- ViiV Healthcare
- National Comprehensive Cancer Network
- Clovis Oncology
- Mylan
- NRG Oncology
- Veracyte
- Cancer Research UK
- National Institute for Health and Care Research
- Imperial College London
- University of Oxford
- Prostate Cancer UK
- University of Leeds
- Bayer HealthCare
- Jean Shanks Foundation
- Eisai
- Astellas Pharma
- Shionogi
- European Society for Medical Oncology
- Ipsen
- Grifols
- National Institutes of Health
- Genentech
- Foundation Medicine
- Medical Research Council
- Menzies Centre for Australian Studies, King's College London, University of London
- Cilag